Video: Generation RX

The deliberate chemical lobotomizing of an entire
generation for profits & societal degeneration

Generation RX

EX G.I. Joe † Ghetto Church † | MySpace Video

Benzo survivor: Gurli Bagnall

Gurli Bagnall's Story
The Birth of The Bounty Hunters

My Experience

In her book "Benzo Junkie", Beatrice Faust tells how one of the fears she used to experience, was sustaining some sort of injury that would leave her brain damaged. In the benzodiazepine experience, she said, the thing she feared most, had happened. It happened to me as well.

I had been married for twenty-one years when, in 1975, my husband and I called it quits. It was a traumatic time and I was not sleeping. My friendly doctor prescribed Ativan, a drug that I had never heard of. Thankfully it worked – but only for a few weeks. "Never mind," he said. "We'll simply double the dose." And from there on, it was all downhill.

I lost a home, a teaching career, financial security, friends and much more. I could only read hesitantly and by the time I got to the second line, I had forgotten what the first was about. I carried a dictionary in my handbag everywhere I went, because I could no longer spell, and when I tried to express myself verbally, the brain would not release the words. I am writing things today, that I could not have read, let alone understood, while I took benzos.

Teaching was out of the question and trying to earn a living by other means – any means – was part of the nightmare and I welcomed the times when I felt so sick, I had to stay home.

In 1983, presenting the typical picture of a benzo addict, I sought the help of another doctor. "I'll give you something that's much better for insomnia," she said as she scribbled out a prescription. "Take these with the Ativan." I had never heard of Halcion either. The nightmare continued with a vengeance.

Apart from work where I was considered to be slow, quiet and withdrawn, I lived in total isolation. My home was my refuge. There I closed the door against the world that judged by what it saw, and dealt with my misery as best I could.

In 1985, with no answers in sight, I tried to commit suicide by taking an overdose. In 1986, I feared that I would lose my job and therefore the small flat I now called home, so the doctor prescribed an anti-depressant – Doxepin. It did nothing except make me put on weight fast and my face became so bloated that I couldn't recognise it in the mirror. "Tut tut!" said my doctor. "You really must exercise self control!"

By May 1989, although still very confused, I felt I had to come off the drugs. I raised the subject fearfully with my doctor who, to my surprise, agreed it would be a good thing to do. But I was shocked when she referred me to the drug and alcoholic clinic of the local hospital. "Why is she sending me there?" I agonised. "I'm not a drug addict. All I've ever taken are the pills she prescribed." Exactly!

I only attended a couple of sessions because even in my befuddled state, I realised the counsellors hadn't a clue what they were dealing with. A social worker took me to a TRANX meeting and I met Vicky, a recovered victim, who made herself available for telephone counselling. She has my life long gratitude.

I dropped the Doxepin straight away; the Ativan took four weeks, but that once-a-day low dose Halcion tablet took me another five months during which it was substituted with Valium for "easier" withdrawal.

In the three years the doctor prescribed Doxepin, my weight had increased by 50%. I now know that excess weight gain and facial oedema are the adverse effects of that drug.

Symptoms of toxicity, withdrawal and post-withdrawal are listed in some medical journals but they are only words. Nowhere are they translated into terms that reflect the human suffering.

In those early days, I learnt that whatever frightening crisis arose (and they came thick and fast), my chances of surviving each event were greater if I rode it out at home alone, for during the first year of being drug free, I nearly died three times due to medical intervention.

During this period I drew a lot of cartoons. They took the dignity from those who claimed respect, but who deserved only contempt. It gave me something to laugh at and helped to defuse the anger.

In 1991, a specialist diagnosed the ongoing post-withdrawal syndrome as the Chronic Fatigue Syndrome. I'd never heard of that before either, but he acknowledged it had been triggered by the benzos. It didn't take long to discover that this diagnosis was like jumping from one very hot frying pan straight into another.

This poorly understood disease has had many names – such as Yuppie Flu which is as trivialising as the CFS. Currently, there is a move afoot to use Myalgic Encephalomyelitis as the official title but that is hotly contested by certain people – particularly within the psychiatric community. They want to claim CFS and all those who suffer it, as their exclusive property.

The WHO categorises it as a disease of the nervous system which, in the benzo context, is no surprise. Nevertheless, just as the medical establishment denied iatrogenesis, so most still deny the disease simply because they do not understand it."

Read more of Gurli's story here
Ordering details for THE BOUNTY HUNTERS are here

Are Prozac and Other Psychiatric Drugs Causing the Rise of Mental illness in America?

Who is Robert Whitaker? Wiki

Bruce Levine interviews Robert Whitaker, author of MAD IN AMERICA:

Bruce Levine: So mental illness disability rates have doubled since 1987 and increased six-fold since 1955. And at the same time, psychiatric drug use greatly increased in the 1950s and 1960s, then skyrocketed after 1988 when Prozac hit the market, so now antidepressant and antipsychotic drugs alone gross more than $25 billion annually in the U.S. But as you know, correlation isn’t causation. What makes you feel that the increase in psychiatric drug use is a big part of the reason for the increase in mental illness?

Robert Whitaker: The rise in the disability rate due to mental illness is simply the starting point for the book. The disability numbers don’t prove anything, but, given that this astonishing increase has occurred in lockstep with our society’s increased use of psychiatric medications, the numbers do raise an obvious question. Could our drug-based paradigm of care, for some unforeseen reason, be fueling the increase in disability rates? And in order to investigate that question, you need to look at two things. First, do psychiatric medications alter the long-term course of mental disorders for the better, or for the worse? Do they increase the likelihood that a person will be able to function well over the long-term, or do they increase the likelihood that a person will end up on disability?

Second, is it possible that a person with a mild disorder may have a bad reaction to an initial drug, and that puts the person onto a path that can lead to long-term disability. For instance, a person with a mild bout of depression may have a manic reaction to an antidepressant, and then is diagnosed with bipolar disorder and put on a cocktail of medications. Does that happen with any frequency? Could that be an iatrogenic [physician-caused illness] pathway that is helping to fuel the increase in the disability rates?

So that’s the starting point for the book. What I then did was look at what the scientific literature -- a literature that now extends over 50 years -- has to say about those questions. And the literature is remarkably consistent in the story it tells. Although psychiatric medications may be effective over the short term, they increase the likelihood that a person will become chronically ill over the long term. I was startled to see this picture emerge over and over again as I traced the long-term outcomes literature for schizophrenia, anxiety, depression, and bipolar illness.

In addition, the scientific literature shows that many patients treated for a milder problem will worsen in response to a drug-- say have a manic episode after taking an antidepressant -- and that can lead to a new and more severe diagnosis like bipolar disorder. That is a well-documented iatrogenic pathway that is helping to fuel the increase in the disability numbers.

Read the rest of the article at Alternet Link

Update: Listen to an interview of Robert Whitaker by Dr. Mercola


Update 2: Robert Whitaker and anti-psych meds articles at
http://www.thestreetspirit.org.
This site is owned by The American Friends Service Committee (AFSC),
a Quaker organization that includes people of various faiths who are committed to social justice and peace.

http://www.thestreetspirit.org/August2005/mad.htm

http://www.thestreetspirit.org/August2005/madinterview.htm

http://www.thestreetspirit.org/August2005/leonards.htm

http://www.thestreetspirit.org/August2005/zyprexa.htm

http://web.archive.org/web/20071119112008/http://www.namiscc.org/newsletters/February02/JohnNashDrugFreeRecovery.htm

Eight invented diseases Pharma is banking on

From Alternet. Link

The Integrity in Science Project

A searchable database reveals the corporate interests behind science studies.

"Our Mission
Over the last thirty years, the commercialization of science in the United States and around the world has increased dramatically. The revolution in genetics, patent protections for bioengineered molecules, laws strengthening intellectual property rights, and the 1980 Bayh-Dole Act authorizing licensing and patenting of results from federally-sponsored research created new incentives for scientists, clinicians, and academic institutions to join forces with for-profit industry in an unprecedented array of entrepreneurial activities.

Although many have cheered partnerships between industry and the research community, it is also acknowledged that they entail conflicts of interest that may compromise the judgment of trusted professionals, the credibility of research institutions and scientific journals, the safety and transparency of human subjects research, the norms of free inquiry, and the legitimacy of science-based policy.

For example:

* There is strong evidence that researchers’ financial ties to chemical, pharmaceutical, or tobacco manufacturers directly influence their published positions in supporting the benefit or downplaying the harm of the manufacturers’ product.
* A growing body of evidence indicates that pharmaceutical industry gifts and inducements bias clinicians’ judgments and influence doctors’ prescribing practices.
* There are well-known cases of industry seeking to discredit or prevent the publication of research results that are critical of its products.
* Studies of life-science faculty indicate that researchers with industry funding are more likely to withhold research results in order to secure commercial advantage.
* Increasingly, the same academic institutions that are responsible for oversight of scientific integrity and human subjects protection are entering financial relationships with the industries whose product-evaluations they oversee.

In response to the commercialization of science and the growing problem of conflicts of interest, the Integrity in Science Project seeks to:

* raise awareness about the role that corporate funding and other corporate interests play in scientific research, oversight, and publication;
* investigate and publicize conflicts of interest and other potentially destructive influences of industry-sponsored science;
* advocate for full disclosure of funding sources by individuals, governmental and non-governmental organizations that conduct, regulate, or provide oversight of scientific investigation or promote specific scientific findings;
* encourage policy-makers at all levels of government to seek balance on expert advisory committees and to provide public, web-based access to conflict-of-interest information collected in the course of committee formation;
* encourage journalists to routinely ask scientists and others about their possible conflicts of interests and to provide this information to the public.


Link

Video: Prescription for Disaster

Link: Prescription for Disaster

From the link:

"It is estimated that in America last year, nearly $2 trillion was spent on health care -- and virtually all that money was spent on treating disease.

Each year more money is spent on treatment, mere patchwork, even though it has become crystal-clear that treatments do NOT enable you to live a longer, better life. So why is the amount of money being spent on prevention just a pittance compared with the amount spent on treatment?

"Prescription for Disaster" is an in-depth investigation into the symbiotic relationships between the pharmaceutical industry, the FDA, lobbyists, lawmakers, medical schools, and researchers, and the impact this has on American consumers and their health care. During this thorough investigation, the film takes a close look at patented drugs, why they are so readily prescribed by doctors, the role insurance companies and HMO's play in promoting compliance, and the problem of rising health care costs. It examines the marketing and public relations efforts on behalf of the pharmaceutical companies, including sales reps, medical journals and conferences. Further, the film looks at alternatives to traditional pharmacology and drug therapy, such as vitamins and nutritional supplements, and why they are often perceived as a competitive threat to the drug manufacturers. Alternative therapies also include diet, exercise and a healthy lifestyle.

This documentary takes you on a journey through the tangled web of big business, the way disease is treated today, and the consequences we suffer as a society."

UK: Scandalous abuse of the elderly - prescribed antipsychotics

From the page:

It is the first time the scale of the abuse in hospital wards is exposed, following warnings that 100,000 dementia patients in care homes are prescribed the drugs leading to the deaths of 23,000 a year

Three quarters of nurses have seen people with dementia in general wards in hospital prescribed antipsychotic drugs that are known to double the risk of death and triple the risk of a stroke in these patients, research has shown.

It is the first time the scale of the abuse in hospital wards is exposed, following warnings that 100,000 dementia patients in care homes are prescribed the drugs leading to the deaths of 23,000 a year.

Ten leading charities, carers groups and experts have written to The Daily Telegraph saying: "We cannot stand by while this scandalous abuse of vulnerable citizens continues."

Neil Hunt, Chief Executive of Alzheimer’s Society said: "The massive over prescription of antipsychotics to people with dementia is an abuse of human rights, causing serious side effects and increasing risk of death. These powerful drugs should only be used in a small number of cases. The Government must take action to ensure that these drugs are only ever used as a last resort."

They have called on the government to publish its long-overdue review of the use of antipsychotics which ministers promised would be out in May of this year.

Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said: "While the Department of Health prevaricates, thousands of people are being put at risk through the misuse of antipsychotics."

There are 700,000 people in Britain with dementia and the numbers are rising rapidly.
Antipsychotics have a sedative effect and are not licensed for use in dementia but are prescribed when patients become agitated or difficult and often then are left on them for long periods.

Link

Misdiagnosed Youngsters? - John Sorboro, MD

Psychiatric News September 6, 2002
Volume 37 Number 17
© 2002 American Psychiatric Association
p. 32
Letter to the Editor

Misdiagnosed Youngsters?

John Sorboro, M.D.
Youngstown, Ohio

"It was with great interest that I read in your June 21 issue a review of the study by Dr. Barbara Geller, "Two-Year Prospective Follow-Up of Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype." This study should be a wake-up call to the legions of psychiatrists who continue to pollute our youth with medications that have no real benefit or solid research to support there use.

I found it most puzzling that the author, while speculating why none of the "treatment" worked but a two-parent home was of benefit, did not consider the most obvious answer: that most of the children in her study (as well as in the United States) whom we call "bipolar" are not. Have we all forgotten what Kraepelin taught us, and how this illness is defined? The psychiatric community needs to recognize the limits of descriptive diagnosis with regard to both treatment and research. Most of us recognize there is a spectrum to this illness, but we must end this practice of labeling all children with mood lability and chaotic behavior—as well as adults with personality disorders—as bipolar.

I have cared for hundreds of adolescents in a residential setting who were diagnosed as bipolar, and many had reported psychotic symptoms. None of them was helped by medications that we acknowledge help adults with manic-depressive illness. Many of the youngsters improved with time because of structured environment and growth. Neuropsychiatric illnesses such as obsessive-compulsive disorder, major depression, and schizophrenia can present in young people, but let’s stop pretending that all behaviorally disordered children have an illness that by definition will never go away.

Have we also forgotten that our first job as physicians is to recognize our limits and to do no harm?"

Link

Drug-Induced Dementia: The Perfect Crime

"Under the influence of declining birth rates, expanding longevity, and changing population structures around the world, the global prevalence of senile dementia is expected to increase more than four-fold within the next forty years. Within the United States alone, the number of affected individuals over the age of 65 is expected to rise exponentially from 8 million cases (2% of the entire population in the year 2000), to 18 million retirees (roughly 4.5% of the national census in the year 2040). Although they are striking, these statistics quite likely underestimate the scope of the coming epidemic, as they fail to consider the impact of under-diagnosis, early-onset disease, and the potential for a changing incidence of illness in the context of increasingly toxic environments.

In the face of this imminent crisis, concerned observers have called for policies and practices which aim to prevent, limit, or reverse dementia. Drug-Induced Dementia: A Perfect Crime is a timely resource which reveals why and how medical treatments themselves – specifically, psychopharmaceuticals – are a substantial cause of brain degeneration and premature death.

A first-of-its-kind resource for patients and clinicians, the book integrates research findings from epidemiology (observational studies of patients in the “real world”), basic biology (animal experiments), and clinical science (neuroimaging and autopsy studies) in order to demonstrate the dementing and deadly effects of psychiatric drugs.

Highlighted by more than 100 neuroimages, slides of tissue specimens, and illustrations, the book uniquely describes:

Ø the societal roots of the problem
(target organ toxicity, regulatory incompetence, and performativity)

Ø the subtypes and essential causes of dementia

Ø the patterns, prevalence, and causes of dementia associated with antidepressants, antipsychotics, anxiolytics, mood stabilizers, and stimulants

and

Ø the actions and reforms which patients, providers, and policy makers might immediately pursue, in an effort to mitigate the causes and consequences of this iatrogenic tragedy."

Link

How Pharma Giants are Getting Rich by Calling Our Life Problems Medical Disorders

Voodoo diagnostics are major mojo for pharmaceutical corporations - and the pshrinks who prescribe.

In 1994, the DSM-IV was published to considerable acclaim, with a text revision released in 2000. A quick glance through its list of contributors is revealing. As was reported in a 2006 study, lead-authored by Lisa Cosgrove of the University of Massachusetts, 56 per cent (95 of 170) of the researchers who worked on the manual had at least one monetary relationship with a drug manufacturer between 1989 and 2004. Twenty-two per cent of these researchers received consulting income during that period, and 16 per cent were paid spokespersons for a drug company. The percentages are even higher – 100 per cent in some instances – for researchers who contributed to the manual’s subsections on psychotic disorders such as schizophrenia. While Cosgrove and her coauthors were not able to determine the percentage of researchers who received funds from the drug industry during the actual production of the DSM-IV, the chorus of protest that arose following their paper’s publication was telling. “I can categorically say,” roared the DSM-IV’s text and criteria editor, Michael First, “that drug-company influence never entered into any of the discussions, whatsoever.”

Images: Dr. John Dee, Elizabethan alchemist and magician, above; and cartoon, The Money Demon, below

Lancet: Principles for allocation of scarce medical interventions

Department of Ethics
The Lancet, Volume 373, Issue 9661, Pages 423 - 431, 31 January 2009
Principles for allocation of scarce medical interventions

Govind Persad BS a, Alan Wertheimer PhD a, Ezekiel J Emanuel MD a
Summary

Allocation of very scarce medical interventions such as organs and vaccines is a persistent ethical challenge. We evaluate eight simple allocation principles that can be classified into four categories: treating people equally, favouring the worst-off, maximising total benefits, and promoting and rewarding social usefulness. No single principle is sufficient to incorporate all morally relevant considerations and therefore individual principles must be combined into multiprinciple allocation systems. We evaluate three systems: the United Network for Organ Sharing points systems, quality-adjusted life-years, and disability-adjusted life-years. We recommend an alternative system—the complete lives system—which prioritises younger people who have not yet lived a complete life, and also incorporates prognosis, save the most lives, lottery, and instrumental value principles.

PDF

UPDATE: Article on end of life care from Alternet -

Obamacare: "Do they really want to croak Granny? - Yes, sometimes"

"While the imposition of this new ethos of death is justly alarming, the more present problem of medical rationing is likely to impact granny much more gravely and much sooner. The rationing of medical treatment for the elderly is marbled throughout the Obama bill in so many places that we will have to address this issue in more detail in a future installment. For example, cancer treatment, much of which is skewed toward an older demographic, will be limited ("adjusted" in Obama-speak, "rationed" in actual English), if it becomes too costly in a particular hospital. (Section 1145) Another example: services to be provided under many plans are quite limited, i.e. rationing. A more attenuated but relevant problem is that hospitals are actually prohibited from expanding, and are limited to their size as of the date of the enactment of the bill, unless a medical politburo, answerable to no one, gives the OK to expand. Thus, treatment options become further limited.

Dr. Ezekiel J. Emanuel, a key medical ethics adviser to the president, and brother of Obama's chief-of-staff Rahm Emanuel, has set forth in writing a deadly formula for allocating care. In a January 31, 2009 article in a prestigious British medical journal, The Lancet, he and two co-authors offer a theory they call, "the complete lives system," as a means to decide who gets care and who dies.

In a complex web of interlocking principles for allocating medical treatment, in an environment where rationing is assumed, Dr. Emanuel opines that teenagers should have priority over infants, because they have received more resources from society. Older people, however, are "objectively less valuable," so, yes, granny does have to die. Under this system, using utilitarian and amoral criteria like "distributive justice," young healthy people from ages 15-40 get priority, and the rest, including grandma, may not.

One can infer that this premise will undergird the implementation of the Obama healthcare regime, including the assumption of rationing of care. While the self-anointed messiah Obama brazenly proclaims throughout the land that his deadly healthcare bill will be good for society, the Hebrew prophet Isaiah rightly saw that such thinking reflects that "the dust of death" has settled over a culture.

The Obama bill reflects the ethos of amoral "utility" throughout. For example, in Section 1177, many plans will not be allowed to enroll "special needs" people. No explanation is given as to the rationale behind this cruel mandate."

Link

NYT: Dr. Drug Rep

Dr. Daniel Carlat tells us how he and other physicians are wooed - and very well paid - to become "Doctor" drug reps.
He is an assistant clinical professor of psychiatry at Tufts University School of Medicine and the publisher of The Carlat Psychiatry Report.

As the reps became comfortable with me, they began to see me more as a sales colleague. I received faxes before talks preparing me for particular doctors. One note informed me that the physician we’d be visiting that day was a “decile 6 doctor and is not prescribing any Effexor XR, so please tailor accordingly. There is also one more doc in the practice that we are not familiar with.” The term “decile 6” is drug-rep jargon for a doctor who prescribes a lot of medications. The higher the “decile” (in a range from 1 to 10), the higher the prescription volume, and the more potentially lucrative that doctor could be for the company.

A note from another rep reminded me of a scene from “Mission: Impossible.” “Dr. Carlat: Our main target, Dr. , is an internist. He spreads his usage among three antidepressants, Celexa, Zoloft and Paxil, at about 25-30 percent each. He is currently using about 6 percent Effexor XR. Our access is very challenging with lunches six months out.” This doctor’s schedule of lunches was filled with reps from other companies; it would be vital to make our sales visit count.+

Naïve as I was, I found myself astonished at the level of detail that drug companies were able to acquire about doctors’ prescribing habits. I asked my reps about it; they told me that they received printouts tracking local doctors’ prescriptions every week. The process is called “prescription data-mining,” in which specialized pharmacy-information companies (like IMS Health and Verispan) buy prescription data from local pharmacies, repackage it, then sell it to pharmaceutical companies. This information is then passed on to the drug reps, who use it to tailor their drug-detailing strategies. This may include deciding which physicians to aim for, as my Wyeth reps did, but it can help sales in other ways. For example, Shahram Ahari, a former drug rep for Eli Lilly (the maker of Prozac) who is now a researcher at the University of California at San Francisco’s School of Pharmacy, said in an article in The Washington Post that as a drug rep he would use this data to find out which doctors were prescribing Prozac’s competitors, like Effexor. Then he would play up specific features of Prozac that contrasted favorably with the other drug, like the ease with which patients can get off Prozac, as compared with the hard time they can have withdrawing from Effexor.

The American Medical Association is also a key player in prescription data-mining. Pharmacies typically will not release doctors’ names to the data-mining companies, but they will release their Drug Enforcement Agency numbers. The A.M.A. licenses its file of U.S. physicians, allowing the data-mining companies to match up D.E.A. numbers to specific physicians. The A.M.A. makes millions in information-leasing money.

Once drug companies have identified the doctors, they must woo them. In the April 2007 issue of the journal PLoS Medicine, Dr. Adriane Fugh-Berman of Georgetown teamed up with Ahari (the former drug rep) to describe the myriad techniques drug reps use to establish relationships with physicians, including inviting them to a speaker’s meeting. These can serve to cement a positive a relationship between the rep and the doctor. This relationship is crucial, they say, since “drug reps increase drug sales by influencing physicians, and they do so with finely titrated doses of friendship.”

Link

Former drug rep Gwen Olsen talks about manipulating doctors.

Top Ten Noteworthy Lobotomies

Link
Wikipedia entry on lobotomy
We hear that nowadays they use pills instead of icepicks. See "chemical lobotomy".

Joanna Moncrieff: The Myth of the Chemical Cure

"...although ideas like the serotonin theory of depression have been widely publicised, scientific research has not detected any reliable abnormalities of the serotonin system in people who are depressed.
Second, it is often said the fact that drug treatment "works" proves there's an underlying biological deficiency.
But there is another explanation for how psychiatric drugs affect people with emotional problems.
It is frequently overlooked that drugs used in psychiatry are psychoactive drugs, like alcohol and cannabis.
Psychoactive drugs make people feel different; they put people into an altered mental and physical state."


This is absolutely true. Pharmaceutical companies put the information right in their products. Package inserts and patient information on SSRI's and other psychoactive drugs often list "altered mental status" as a side effect.

In fact, altered mental status is listed in the
Merck Veterinary Manual!

In some countries physicians are not even required to tell patients about such adverse drug effects; legally, they are permitted to leave that job to the pharmacist who fills the script. Once you have decided to fill a script, it may already be too late.


BBC Link
Dr. Moncreiff's site at University College London
Article from news at UCL
Link to her book

Michael Jackson: "They keep feeding him pills like candy"

If good can come out of the death of Michael Jackson, it may be through raising awareness that medications may not be our friends. Link (Globe&Mail)
As we read this chapter from a new book on Michael Jackson, we are struck by how many of his traits - anorexia, pain, eccentricity and isolation - resemble nutritional deficiency conditions called Pyroluria and Histadelia.

This bizarre story after the death of MJ reminds us in a different way that meds are not our friends -
Seroquel murder-suicide

Deepak Chopra on Michael Jackson and Enabling Doctors

A list of the cocktail of drugs Michael Jackson was taking when he died can be seen here.

Dr. Deepak Chopra was a friend of Jackson's. He writes about Jackson's death on his blog at The Huffington Post.

"The public's attention span is short, but widespread awareness is the first step. The real target audience are the local licensing boards and peer review committees who handle medical practice. The culture of "just say yes" when a celebrity shows up in a doctor's office needs to be condemned. This condemnation needs to be followed up with serious consequences for enabling physicians. If they recklessly addict a patient, severe repercussions should follow. If they themselves are addicted, complete abstinence must be achieved before they are allowed to return to medical practice, and random drug testing should be required by all states. Computerized medical histories should be instituted, so that we know precisely how many prescriptions are being written by each doctor and filled by each patient. With a centralized database, celebrities won't be able to pull off the trick of fooling dozens doctors and pharmacists all over town. And we need to do a better job educating physicians about the nuances and difficulties of treating patients such as these.

These steps are a beginning. Realistically, celebrities will always be first in line in gaining easy access to drugs. They have the means, the excuses, the money, and the opportunity. But at the very least the culture of enabling physicians must be branded as shameful. The same image that fools the public has eroded medical ethics. The abuse of prescription medication is becoming an alarming problem in this country, It's not fun to take drugs, it is serious business as is our charge to care for patients, celebrity or not. Doctors that enable celebrities must be brought to justice or else we will continue to witness shattered lives and sudden death."

Link
Chopra says Jackson's death due to drugs More

Lilly ‘Ghostwrote’ Articles to Market Drug, Files Say

From Bloomberg: Link

Lilly ‘Ghostwrote’ Articles to Market Drug, Files Say (Update2)

By Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk

June 11 (Bloomberg) -- Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting,” according to unsealed company files.

Lilly employees also compiled a guide to hiring scientists to write favorable articles, complained to journal editors when publication was delayed and submitted rejected articles to other outlets, according to documents filed in drug-overpricing suits against the Indianapolis-based company, the largest manufacturer of psychiatric medicines.

Drugmakers’ use of ghostwriters has created “a huge body of medical literature that society can’t trust,” said Carl Elliott, a University of Minnesota bioethicist who has written about the practice. "

Also see this article.

Senator Grassley Posts Researchers' Drug Company Ties

Senator Grassley writes,

I’m working to shed light on financial relationships between drug companies and doctors. I’ve conducted oversight, and I’m working for passage of legislation that would require public reporting by drug companies of the money they give to doctors for consulting, travel, speeches, meals and other activities. The public interest is clear. We all rely on the advice of doctors, and leading researchers influence the practice of medicine. Taxpayers spend billions of dollars each year on prescription drugs and devices through Medicare and Medicaid. The National Institutes of Health distributes $24 billion annually in federal research grants. So the public has a right to know about financial relationships between doctors and drug companies.

The link offers a collection of names and ties of the famous, powerful - and trusted. Go see for yourself.
PDF
Our previous coverage of Senator Grassley is Pharmaceuticals Anonymous: Bloomberg: NAMI to be probed re Pharma ties> here.

Osler on Medicine

The first duty of the physician is to educate the masses not to take medicine.
- Sir William Osler
You may also like the interesting Osler quotes
here.